Ozkan, M. Et Al. 2015. Ultraslow thrombolytic therapy: A novel strategy in the management of PROsthetic MEchanical valve Thrombosis and the prEdictors of outcomE: The Ultra-slow PROMETEE trial. AMERICAN HEART JOURNAL , vol.170, no.2 , 409-419.

Ozkan, M., Gunduz, S., Gursoy, O. M., Karakoyun, S., ASTARCIOĞLU, M. A., Kalcik, M., ... Aykan, A. C.(2015). Ultraslow thrombolytic therapy: A novel strategy in the management of PROsthetic MEchanical valve Thrombosis and the prEdictors of outcomE: The Ultra-slow PROMETEE trial. AMERICAN HEART JOURNAL , vol.170, no.2, 409-419.

Ozkan, Mehmet Et Al. "Ultraslow thrombolytic therapy: A novel strategy in the management of PROsthetic MEchanical valve Thrombosis and the prEdictors of outcomE: The Ultra-slow PROMETEE trial," AMERICAN HEART JOURNAL , vol.170, no.2, 409-419, 2015

Ozkan, Mehmet Et Al. "Ultraslow thrombolytic therapy: A novel strategy in the management of PROsthetic MEchanical valve Thrombosis and the prEdictors of outcomE: The Ultra-slow PROMETEE trial." AMERICAN HEART JOURNAL , vol.170, no.2, pp.409-419, 2015

Ozkan, M. Et Al. (2015) . "Ultraslow thrombolytic therapy: A novel strategy in the management of PROsthetic MEchanical valve Thrombosis and the prEdictors of outcomE: The Ultra-slow PROMETEE trial." AMERICAN HEART JOURNAL , vol.170, no.2, pp.409-419.

@article{article, author={Mehmet Ozkan Et Al. }, title={Ultraslow thrombolytic therapy: A novel strategy in the management of PROsthetic MEchanical valve Thrombosis and the prEdictors of outcomE: The Ultra-slow PROMETEE trial}, journal={AMERICAN HEART JOURNAL}, year=2015, pages={409-419} }